Marketer of the Year: Unilever / Dec. 9, 2020
https://www.marketingdive.com/news/marketer-of-year-unilever-2020/589039/
"Last summer, Unilever committed to removing phrases like "whitening" from
its products while rebranding its Fair & Lovely of skin-lightening cosmetics."
---
What to know about dark knees / December 9, 2020
https://www.medicalnewstoday.com/articles/dark-knees#contacting-a-doctor
"However, if a person wants to try lightening their knees for aesthetic reasons,
they can try several different methods to treat their pigmentation at home."
---
Fairly Unfair: Skin Lightening in the Modern Era / December 9, 2020
https://www.northeasttoday.in/2020/12/09/fairly-unfair-skin-lightening-in-the-modern-era/
"There are alarming rates of skin lightening in India. In one study, all 4368 patients who
visited the dermatology department of an Indian hospital reported adverse effects of skin
lightening which indicates their use or misuse of skin lighteners."
---
First SGLT2 approved for heart condition / 10 Dec 2020
https://www1.racgp.org.au/newsgp/clinical/first-sglt2-approved-for-heart-condition
"Dapagliflozin (sold as Forxiga) has been extended to include the treatment of symptomatic
heart failure with reduced ejection fraction (systolic heart failure) in adults, as an
addition to the current standard of care."
---
Dr. Giorgino discusses how combining SGLT2 Inhibitors and GLP-1RA could be combined for treating type 2 diabetes.
https://www.hcplive.com/view/giorgino-diabetes-treatment-sglt2-inhibitors
"A major breakthrough in diabetes treatment in the last few years has been the advent of SGLT2 inhibitors"
---
Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003451
"Though diabetes affects approximately 8.3% of the world population, a large fraction of patients is undiagnosed, accounting for 21.4% out
of 34.1 million and 63.5% out of 114.4 million American and Chinese adult diabetes cases"
--- only mind games, my favorite for the big deal
Boehringer Ingelheim invests to further develop the pet care market in China / September 29, 2020
https://www.boehringer-ingelheim.com/press-release/partnership-further-develop-pet-market-china
"China’s pet market is one of thefastest growing markets in the world."
Boehringer Ingelheim Creates New China External Innovation Hub / 20.07.2020
https://pharmaboardroom.com/articles/boehringer-ingelheim-creates-new-china-rd-hub/
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance / 1 January 2020
https://www.boehringer-ingelheim.com/press-release/new-focus-boehringer-ingelheim-and-lilly-alliance
Milestone for Biopharmaceuticals in China / December 30th, 2019
https://www.boehringer-ingelheim.com/press-release/biopharmaceuticals-china
Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities / January 17, 2019
https://www.boehringer-ingelheim.com/press-release/capacityexpansionoasis